Pegylated interferon (PEG-Intron) for chronic hepatitis C
Medical Letter on Drugs and Therapeutics 43(1107): 54-55
2001
ISSN/ISBN: 0025-732X PMID: 11426190 Document Number: 540016
Document emailed within 1 workday
Related Documents
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130Cianciara, J.; Laskus, T.; Hryniewicz, H.; Jabłońska, J.; Loch, T. 1991: Treatment of chronic hepatitis B with interferon alfa-2b (Intron A) Przeglad Epidemiologiczny 45(4): 315-320
Čalkić, L.; Bajramović-Omeragić, L.; Husić-Selimović, A.; Aličković, I. 2017: Hbsag Seroconversion in the Treatment of Chronic Hepatitis B with Pegylated Interferon Lijecnicki Vjesnik 139(1-2): 29-32
Pawłowska, M.łg.; Halota, W. 2006: Pegylated interferon alpha in the treatment of chronic hepatitis B in HBe negative patients Przeglad Epidemiologiczny 60(1): 105-108
Juszczyk, J.; Baka-Cwierz, B.; Beniowski, M.; Berak, H.; Bolewska, B.; Boroń-Kaczmarska, A.; Cianciara, J.; Cieśla, A.; Dziambor, A.; Gasiorowski, J.; Gietka, A.; Gliwińska, E.; Gładysz, A.; Gonciarz, Z.; Halota, W.; Horban, A.; Inglot, Młgorzata.; Janas-Skulina, U.; Janczewska-Kazek, E.; Jaskowska, J.; Jurczyk, K.; Knysz, B.; Kryczka, Wław.; Kuydowicz, J.; Lakomy, E.A.; Logiewa-Bazger, B.; Lyczak, A.; Mach, T.; Mazur, Włodzimierz.; Michalska, Z.; Modrzewska, R.; Nazzal, K.; Pabjan, Pł.; Piekarska, A.; Piszko, Pł.; Sikorska, K.; Szamotulska, K.; Sliwińska, M 2005: Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report) Przeglad Epidemiologiczny 59(3): 651-660
Sarin, S.K.; Kumar, M.; Hissar, S.; Sharma, B.C. 2006: Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment Hepatobiliary and Pancreatic Diseases International: Hbpd Int 5(3): 374-380
Słuzewski, W.; Kowala-Piaskowska, A.; Wysocki, J.; Figlerowicz, M.; Gorczyca, A.; Halota, W.; Jóźwiak, H.; Mizerski, J.; Mozer-Lisewska, I.; Pawłowska, M.łg.; Rokitka, M.; Strawińska, E.; Szamotulska, K. 2012: Treatment of chronic hepatitis C in children with pegylated interferon α2a and ribavirin--a multi-center study Acta Poloniae Pharmaceutica 69(2): 319-326
Husa, P.; Husova, L. 2001: Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons Bratislavske Lekarske Listy 102(5): 248-252
Ferenci, P. 2006: Pegylated interferon plus ribavirin for chronic hepatitis C: the role of combination therapy today, tomorrow and in the future Minerva Gastroenterologica e Dietologica 52(2): 157-174
Mozer-Lisewska, I.; Dworacki, G.; Kaczmarek, E.; Słuzewski, W.; Kowala-Piaskowska, A.; Figlerowicz, M.; Kaczmarek, M.; Zeromski, J. 2005: Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin Przeglad Epidemiologiczny 59(2): 483-489
Elefsiniotis, I.S.; Fotos, N.V.; Pantazis, K.D.; Papadeli, D.; Mavrogiannis, C. 2007: Celiac disease in chronic hepatitis C patients under pegylated-interferon plus ribavirin treatment. Preliminary results of a prospective single center study Hepato-Gastroenterology 54(75): 2 PPreceding Table of Contents
Durante-Mangoni, E.; Iardino, P.; Utili, R.; Adinolfi, L.E.; Ruggiero, G. 2006: Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts Antiviral Therapy 11(5): 637-640
Srivastava, S.; Bertagnolli, M.; Lewis, J.H. 2005: Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic Journal of the National Medical Association 97(12): 1703-1707
Vogel, M.; Nattermann, J.; Baumgarten, A.; Klausen, G.; Bieniek, B.; Schewe, K.; Jessen, H.; Boesecke, C.; Rausch, M.; Lutz, T.; Fenske, S.; Schranzo, D.; Kümmerle, T.; Schuler, C.; Theisen, A.; Mayr, C.; Seidel, T.; Rockstroh, J.ür.K. 2006: Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals Antiviral Therapy 11(8): 1097-1101
Gallina, K.; Brodell, R.T.; Naffah, F.; Nedorost, S. 2003: Local blistering reaction complicating subcutaneous injection of pegylated interferon in a patient with hepatitis C Journal of Drugs in Dermatology: Jdd 2(1): 63-67
Tsertsvadze, T.; Sharvadze, L.; Metreveli, D.; Ruadze, E. 2017: Prospective Observational Cohort Study of Predictors of the Effectiveness of Pegylated Interferon in Patients with Hepatitis C in Georgia Georgian Medical News 265: 30-40
Abutidze, A.; Bolokadze, N.; Chkhartishvili, N.; Sharvadze, L.; Tsertsvadze, T. 2016: Incidence of Tuberculosis among Hiv/Hcv Co-Infected Patients Receiving Hepatitis C Treatment with Pegylated Interferon and Ribavirin in Georgia Georgian Medical News 252: 10-15
Chu, C-Jen.; Wang, Y-Jen.; Hwang, S-Jang.; Lu, R-Hwa.; Chang, F-Young.; Chang, C-Yu.; Yang, Y-Chun.; Lee, S-Dong. 2007: Kinetics of hepatitis C virus RNA load during pegylated interferon plus ribavirin therapy in Treatment-naive Chinese patients Hepato-Gastroenterology 54(75): 866-870
Vashakidze, E.; Imnadze, T. 2017: Combined Antiviral Treatment of Hepatitis C Virus Infection with Pegylated Interferon (Peg-Ifn) Α-2a (Pegferon) and Ribavirin (Copegus) in Inmates Georgian Medical News 264: 86-90
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042